Katie McKenna

Assistant Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Katie McKenna is an Assistant Professor at Baylor College of Medicine in the United States. Her research focuses on CAR T-cell therapy, with recent studies exploring novel strategies to enhance tumor infiltration and target pancreatic tumors, as well as the role of the splenic microenvironment in chronic lymphocytic leukemia. She is also involved in investigating the impact of manufacturing procedures on CAR T-cell functionality and strategies to enhance antitumor activity through novel immunotherapy approaches.

Articles (10)

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Norihiro Watanabe

Baylor College of Medicine

UNITED STATES

View details

Natarajan Muthusamy

UNITED STATES

View details

Challice Bonifant

Assistant Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Johannes Stadlmann

BOKU University

AUSTRIA

View details

Maksim Mamonkin

Baylor College of Medicine

UNITED STATES

View details

Amanda Rosewell Shaw

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Masataka Suzuki

Baylor College of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katie McKenna

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Tunneling CARs: Increasing CAR T-cell tumor infiltration through the overexpression of MMP-7 and Osteopontin-b

Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma

Impact of Manufacturing Procedures on CAR T Cell Functionality.

Targeting glycans for CAR therapy: The advent of sweet CARs.

Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eµ-TCL1 transgenic mice

Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy.

Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.

Generation of CAR T-cells using γ-retroviral vector.

Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors

Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity.

Collaborators (7)

Norihiro Watanabe

Natarajan Muthusamy

Challice Bonifant

Johannes Stadlmann

Maksim Mamonkin

Amanda Rosewell Shaw

Masataka Suzuki

Make your next move.